Emmanuel Ampofo

1.6k citations
67 papers · 867 indexed · h-index 18
Topics
Pancreatic function and diabetes (19 papers)Angiogenesis and VEGF in Cancer (8 papers)Endoplasmic Reticulum Stress and Disease (7 papers)
Partner nations
GermanySwitzerlandChina

In The Last Decade

Emmanuel Ampofo

64 papers receiving 853 citations

Peers

Emmanuel Ampofo
Comparison fields: 5 of 95
  • Molecular Biology 434
  • Surgery 252
  • Cancer Research 118
  • Cell Biology 110
  • Oncology 94
Replace Han Na Suh with:
Han Na Suh South Korea
Shihori Tanabe Japan
Caroline O’Neil Canada
Gilda Cobellis Italy
Kevin Taylor United States
Jungsul Lee South Korea
Shuchen Gu China
Chantal Allamargot United States
Hitomi Nishinakamura Japan
Maribel Muñoz‐Martín Spain
Emmanuel Ampofo relative to Han Na Suh South Korea Han Na Suh's profile →
Citations per field
00.5×1.5×2.2×
Han Na Suh · 1×
Citations per year

Countries citing papers authored by Emmanuel Ampofo

Since Specialization
Citations

This map shows the geographic impact of Emmanuel Ampofo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emmanuel Ampofo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emmanuel Ampofo more than expected).

Fields of papers citing papers by Emmanuel Ampofo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emmanuel Ampofo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emmanuel Ampofo. The network helps show where Emmanuel Ampofo may publish in the future.

Co-authorship network of co-authors of Emmanuel Ampofo

This figure shows the co-authorship network connecting the top 25 collaborators of Emmanuel Ampofo. A scholar is included among the top collaborators of Emmanuel Ampofo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emmanuel Ampofo. Emmanuel Ampofo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 2
4 1
5 7
6 1
7 1
8 2
9 1
10 13
11 3
12 4
13 4
14 23
15 76
16 11
17 5
18 20
19 26
20 24

About Emmanuel Ampofo

Emmanuel Ampofo is a scholar working on Immunology and Allergy, Surgery and Hematology, having authored 67 papers that have together received 867 indexed citations. Recurring topics across this work include Pancreatic function and diabetes (19 papers), Angiogenesis and VEGF in Cancer (8 papers) and Endoplasmic Reticulum Stress and Disease (7 papers). The work is most often cited by research in Cancer Research (118 citations), Cell Biology (110 citations) and Molecular Biology (434 citations). Emmanuel Ampofo has collaborated with scholars based in Germany, Switzerland and China. Frequent co-authors include Michael D. Menger, Matthias W. Laschke, Mathias Montenarh, Lisa Nalbach, B. Schmitt, Claudia Götz, Yuan Gu, Letícia Prates Roma, Thomas Später and Andrea Weinzierl. Their work appears in journals such as Nature Communications, Blood and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026